Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1995 Dec;54(12):983–987. doi: 10.1136/ard.54.12.983

HLA class II genes associated with anticentromere antibody in Japanese patients with systemic sclerosis (scleroderma).

M Kuwana 1, Y Okano 1, J Kaburaki 1, H Inoko 1
PMCID: PMC1010064  PMID: 8546531

Abstract

OBJECTIVE--To define further HLA class II gene associations with anticentromere antibody (ACA), a major serum antinuclear antibody in patients with systemic sclerosis (SSc). METHODS--HLA class II genes were determined using polymerase chain reaction/restriction fragment length polymorphisms in 94 Japanese patients with SSc (22 ACA positive and 72 ACA negative) and 50 race matched normal control subjects. RESULTS--Frequency of DQB1*0501 was increased in ACA positive SSc patients compared with ACA negative SSc patients (36% versus 13%; p = 0.02, odds ratio = 4.0, 95% confidence interval 1.1 to 13.9), but the association of ACA with a polar amino acid at position 26 in the DQB1 beta 1 domain, which was demonstrated in white North Americans, was not observed in Japanese. The DRB1*0101, *0405, and *1302 alleles were associated with high ACA titres, whereas DRB1*1502 was associated with low ACA titres and a low frequency of centromere protein C (CENP-C) reactivity. CONCLUSIONS--These results suggest that the ACA response is associated with multiple HLA class II genes and that ACA positive SSc patients are heterogeneous in terms of immunogenetic background.

Full text

PDF
983

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Briggs D., Stephens C., Vaughan R., Welsh K., Black C. A molecular and serologic analysis of the major histocompatibility complex and complement component C4 in systemic sclerosis. Arthritis Rheum. 1993 Jul;36(7):943–954. doi: 10.1002/art.1780360711. [DOI] [PubMed] [Google Scholar]
  2. Dunckley H., Jazwinska E. C., Gatenby P. A., Serjeantson S. W. DNA-DR typing shows HLA-DRw11 RFLPs are increased in frequency in both progressive systemic sclerosis and CREST variants of scleroderma. Tissue Antigens. 1989 Mar;33(3):418–420. doi: 10.1111/j.1399-0039.1989.tb01686.x. [DOI] [PubMed] [Google Scholar]
  3. Earnshaw W. C., Sullivan K. F., Machlin P. S., Cooke C. A., Kaiser D. A., Pollard T. D., Rothfield N. F., Cleveland D. W. Molecular cloning of cDNA for CENP-B, the major human centromere autoantigen. J Cell Biol. 1987 Apr;104(4):817–829. doi: 10.1083/jcb.104.4.817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Earnshaw W., Bordwell B., Marino C., Rothfield N. Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies. J Clin Invest. 1986 Feb;77(2):426–430. doi: 10.1172/JCI112320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Genth E., Mierau R., Genetzky P., von Mühlen C. A., Kaufmann S., von Wilmowsky H., Meurer M., Krieg T., Pollmann H. J., Hartl P. W. Immunogenetic associations of scleroderma-related antinuclear antibodies. Arthritis Rheum. 1990 May;33(5):657–665. doi: 10.1002/art.1780330508. [DOI] [PubMed] [Google Scholar]
  6. Kuwana M., Kaburaki J., Okano Y., Inoko H., Tsuji K. The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma). J Clin Invest. 1993 Sep;92(3):1296–1301. doi: 10.1172/JCI116703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kuwana M., Kaburaki J., Okano Y., Tojo T., Homma M. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum. 1994 Jan;37(1):75–83. doi: 10.1002/art.1780370111. [DOI] [PubMed] [Google Scholar]
  8. Kuwana M., Medsger T. A., Jr, Wright T. M. T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors. J Clin Invest. 1995 Jul;96(1):586–596. doi: 10.1172/JCI118071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kuwana M., Okano Y., Kaburaki J., Tojo T., Medsger T. A., Jr Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies. Arthritis Rheum. 1994 Jun;37(6):902–906. doi: 10.1002/art.1780370619. [DOI] [PubMed] [Google Scholar]
  10. Kuwana M., Okano Y., Kaburaki J., Tsuji K., Inoko H. Major histocompatibility complex class II gene associations with anti-U1 small nuclear ribonucleoprotein antibody. Relationship to immunoreactivity with individual constituent proteins. Arthritis Rheum. 1995 Mar;38(3):396–405. doi: 10.1002/art.1780380317. [DOI] [PubMed] [Google Scholar]
  11. McHugh N. J., Whyte J., Artlett C., Briggs D. C., Stephens C. O., Olsen N. J., Gusseva N. G., Maddison P. J., Black C. M., Welsh K. Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: a serological and HLA study. Clin Exp Immunol. 1994 May;96(2):267–274. doi: 10.1111/j.1365-2249.1994.tb06552.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Morel P. A., Chang H. J., Wilson J. W., Conte C., Falkner D., Tweardy D. J., Medsger T. A., Jr HLA and ethnic associations among systemic sclerosis patients with anticentromere antibodies. Hum Immunol. 1995 Jan;42(1):35–42. doi: 10.1016/0198-8859(94)00078-5. [DOI] [PubMed] [Google Scholar]
  13. Moroi Y., Peebles C., Fritzler M. J., Steigerwald J., Tan E. M. Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1627–1631. doi: 10.1073/pnas.77.3.1627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Reveille J. D., Durban E., MacLeod-St Clair M. J., Goldstein R., Moreda R., Altman R. D., Arnett F. C. Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest. 1992 Sep;90(3):973–980. doi: 10.1172/JCI115974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Reveille J. D. Molecular genetics of systemic sclerosis. Curr Opin Rheumatol. 1993 Nov;5(6):753–759. doi: 10.1097/00002281-199305060-00010. [DOI] [PubMed] [Google Scholar]
  16. Reveille J. D., Owerbach D., Goldstein R., Moreda R., Isern R. A., Arnett F. C. Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma). J Clin Invest. 1992 Apr;89(4):1208–1213. doi: 10.1172/JCI115704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Steen V. D., Powell D. L., Medsger T. A., Jr Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum. 1988 Feb;31(2):196–203. doi: 10.1002/art.1780310207. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES